Sale!

Immunophenotyping by Flow Cytometry CD20 Test Cost

Original price was: 530 د.إ.Current price is: 480 د.إ.

-9%

Immunophenotyping by Flow Cytometry CD20 Test is a specialized diagnostic procedure performed at DNA Labs UAE. Priced at 480 AED, this test plays a critical role in the identification and classification of various types of blood cell cancers, including lymphomas and leukemias. The CD20 marker, targeted in this test, is primarily found on the surface of B cells, a type of white blood cell crucial for the immune response. By using flow cytometry technology, the test accurately quantifies the presence of cells expressing the CD20 antigen, thereby aiding in the diagnosis, prognosis, and treatment planning for patients with certain hematological malignancies. This precise and targeted approach ensures that clinicians can develop more effective, individualized treatment strategies for affected patients.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD20 Test

Test Name: IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD20 Test

Components: CD20 Test

Price: 480.0 AED

Sample Condition: 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube and 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Specify time, date, and clinical details on the test request form.

Report Delivery: Sample Daily by 9 am; Report Same day

Method: Flow Cytometry

Test Type: Cancer

Doctor: Oncologist, Hematologist

Test Department: FLOW CYTOMETRY

Pre Test Information: Give brief clinical history.

Test Details:

CD20 is a cell surface protein that is primarily expressed on B cells, including normal B cells and B-cell lymphomas. Immunophenotyping by flow cytometry using CD20 antibodies allows for the identification and quantification of B cells in a sample.

The CD20 test is commonly used in the diagnosis and monitoring of B-cell lymphomas, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. It can also be used to assess the effectiveness of targeted therapies that specifically target CD20, such as rituximab.

During the CD20 test, cells from a patient’s sample (such as blood or bone marrow) are stained with fluorescently labeled CD20 antibodies. The stained cells are then passed through a flow cytometer, a specialized instrument that can analyze and sort cells based on their fluorescence properties.

The flow cytometer detects the fluorescence emitted by the CD20 antibodies and generates data on the number and characteristics of CD20-positive cells in the sample. This data can then be analyzed to determine the percentage of B cells, as well as any abnormalities or changes in the B-cell population.

Overall, immunophenotyping by flow cytometry using CD20 antibodies is a valuable tool in the diagnosis and monitoring of B-cell lymphomas, providing important information about the B-cell population in a patient’s sample.

Test Name IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD20 Test
Components
Price 480.0 AED
Sample Condition 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tubeAND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on test request form.
Report Delivery Sample Daily by 9 am;Report Same day
Method Flow Cytometry
Test type Cancer
Doctor Oncologist, Hematologist
Test Department: FLOW CYTOMETRY
Pre Test Information Give brief clinical history.
Test Details

CD20 is a cell surface protein that is primarily expressed on B cells, including normal B cells and B-cell lymphomas. Immunophenotyping by flow cytometry using CD20 antibodies allows for the identification and quantification of B cells in a sample.

The CD20 test is commonly used in the diagnosis and monitoring of B-cell lymphomas, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. It can also be used to assess the effectiveness of targeted therapies that specifically target CD20, such as rituximab.

During the CD20 test, cells from a patient’s sample (such as blood or bone marrow) are stained with fluorescently labeled CD20 antibodies. The stained cells are then passed through a flow cytometer, a specialized instrument that can analyze and sort cells based on their fluorescence properties.

The flow cytometer detects the fluorescence emitted by the CD20 antibodies and generates data on the number and characteristics of CD20-positive cells in the sample. This data can then be analyzed to determine the percentage of B cells, as well as any abnormalities or changes in the B-cell population.

Overall, immunophenotyping by flow cytometry using CD20 antibodies is a valuable tool in the diagnosis and monitoring of B-cell lymphomas, providing important information about the B-cell population in a patient’s sample.